Your browser doesn't support javascript.
"Death Diamond" Tracing on Thromboelastography as a Marker of Poor Survival After Trauma.
Farrell, Michael S; Moore, Ernest E; Thomas, Anthony V; Coleman, Julia R; Thomas, Scott; Vande Lune, Stefani; Marconi, Thomas; Cohen, Mitchell J; Chapman, Michael P; Moore, Hunter B; Walsh, Mark M; Sixta, Sherry.
  • Farrell MS; Departments of Trauma, Surgery, and Critical Care Medicine, 5973Christiana Care Health Services, Wilmington, DE, USA.
  • Moore EE; Department of Surgery, 129263University of Colorado-Anschutz Medical Campus, Aurora, CO, USA.
  • Thomas AV; Department of Surgery, Ernest E. Moore Shock Trauma Center at Denver Health, Denver, CO, USA.
  • Coleman JR; 158720Notre Dame Campus, Indiana University School of Medicine, South Bend, IN, USA.
  • Thomas S; Departments of Emergency and Internal Medicine, Saint Joseph Regional Medical Center, Mishawaka, IN, USA.
  • Vande Lune S; Department of Surgery, 129263University of Colorado-Anschutz Medical Campus, Aurora, CO, USA.
  • Marconi T; Memorial Trauma Center, Memorial Hospital, South Bend, IN, USA.
  • Cohen MJ; Emergency Medicine Department, Navy Medicine Readiness and Training Command, Portsmouth, VA, USA.
  • Chapman MP; Departments of Trauma, Surgery, and Critical Care Medicine, 5973Christiana Care Health Services, Wilmington, DE, USA.
  • Moore HB; Department of Surgery, 129263University of Colorado-Anschutz Medical Campus, Aurora, CO, USA.
  • Walsh MM; Department of Surgery, Ernest E. Moore Shock Trauma Center at Denver Health, Denver, CO, USA.
  • Sixta S; Department of Radiology, University of Colorado-Denver, Denver, CO, USA.
Am Surg ; 88(7): 1689-1693, 2022 Jul.
Article in English | MEDLINE | ID: covidwho-1892040
ABSTRACT

BACKGROUND:

Improvements in health care innovations have resulted in an enhanced ability to extend patient viability. As a consequence, resources are being increasingly utilized at an unsustainable level. As we implement novel treatments, identifying futility should be a focus. The "death diamond" (DD) is a unique thrombelastography (TEG) tracing that is indicative of failure of the coagulation system, with a mortality rate exceeding 90%. The purpose of this study was to determine if the DD was a consistent marker of poor survival in a multicenter study population. We hypothesize that the DD, while an infrequent occurrence, predicts poor survival and can be used to stratify patients in whom resuscitation efforts are futile.

METHODS:

A retrospective multi-institutional study of trauma patients presenting with TEG DDs between 8/2008 and 12/2018 at four American College of Surgeons trauma centers was completed. Demographics, injury mechanisms, TEG results, management, and survival were examined.

RESULTS:

A total of 50 trauma patients presented with DD tracings, with a 94% (n = 47) mortality rate. Twenty-six (52%) patients received a repeat TEG with 10 patients re-demonstrating the DD tracing. There was 100% mortality in patients with serial DD tracings. The median use of total blood products was 18 units (interquartile range 6, 34.25) per patient.

DISCUSSION:

The DD is highly predictive of trauma-associated mortality. This multicenter study highlights that serial DDs may represent a possible biomarker of futility.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Wounds and Injuries / Blood Coagulation Disorders Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: Am Surg Year: 2022 Document Type: Article Affiliation country: 0003134821998684

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Wounds and Injuries / Blood Coagulation Disorders Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: Am Surg Year: 2022 Document Type: Article Affiliation country: 0003134821998684